AU2012245211B2 - Wearable automatic injection device - Google Patents
Wearable automatic injection device Download PDFInfo
- Publication number
- AU2012245211B2 AU2012245211B2 AU2012245211A AU2012245211A AU2012245211B2 AU 2012245211 B2 AU2012245211 B2 AU 2012245211B2 AU 2012245211 A AU2012245211 A AU 2012245211A AU 2012245211 A AU2012245211 A AU 2012245211A AU 2012245211 B2 AU2012245211 B2 AU 2012245211B2
- Authority
- AU
- Australia
- Prior art keywords
- administration
- therapeutic agent
- administration interface
- automatic injection
- injection device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000002347 injection Methods 0.000 title claims abstract description 374
- 239000007924 injection Substances 0.000 title claims abstract description 374
- 239000003814 drug Substances 0.000 claims abstract description 455
- 229940124597 therapeutic agent Drugs 0.000 claims abstract description 450
- 238000000034 method Methods 0.000 claims abstract description 68
- 230000007246 mechanism Effects 0.000 claims description 290
- 239000012530 fluid Substances 0.000 claims description 211
- 230000001681 protective effect Effects 0.000 claims description 67
- 238000004891 communication Methods 0.000 claims description 52
- 230000036512 infertility Effects 0.000 claims description 47
- 108700012920 TNF Proteins 0.000 claims description 31
- 230000004888 barrier function Effects 0.000 claims description 28
- 230000037361 pathway Effects 0.000 claims description 28
- 239000003112 inhibitor Substances 0.000 claims description 20
- 238000003780 insertion Methods 0.000 claims description 16
- 230000037431 insertion Effects 0.000 claims description 16
- 238000013016 damping Methods 0.000 claims description 14
- 230000004913 activation Effects 0.000 claims description 6
- 238000011144 upstream manufacturing Methods 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 4
- 230000000149 penetrating effect Effects 0.000 claims description 4
- 238000012546 transfer Methods 0.000 description 61
- 239000012790 adhesive layer Substances 0.000 description 53
- 238000004806 packaging method and process Methods 0.000 description 34
- 230000033001 locomotion Effects 0.000 description 33
- 239000000126 substance Substances 0.000 description 20
- 230000000994 depressogenic effect Effects 0.000 description 18
- 239000000463 material Substances 0.000 description 16
- 239000000853 adhesive Substances 0.000 description 15
- 239000007789 gas Substances 0.000 description 15
- 238000002560 therapeutic procedure Methods 0.000 description 15
- 230000001070 adhesive effect Effects 0.000 description 14
- 230000001960 triggered effect Effects 0.000 description 14
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 13
- 239000012634 fragment Substances 0.000 description 13
- 230000035807 sensation Effects 0.000 description 13
- 230000000007 visual effect Effects 0.000 description 13
- 239000000427 antigen Substances 0.000 description 12
- 108091007433 antigens Proteins 0.000 description 12
- 102000036639 antigens Human genes 0.000 description 12
- 230000008878 coupling Effects 0.000 description 12
- 238000010168 coupling process Methods 0.000 description 12
- 238000005859 coupling reaction Methods 0.000 description 12
- 229960002964 adalimumab Drugs 0.000 description 11
- 230000001225 therapeutic effect Effects 0.000 description 11
- 238000011200 topical administration Methods 0.000 description 11
- -1 for example Proteins 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 108060003951 Immunoglobulin Proteins 0.000 description 8
- 102000018358 immunoglobulin Human genes 0.000 description 8
- 229960000598 infliximab Drugs 0.000 description 8
- 238000013270 controlled release Methods 0.000 description 7
- 238000007918 intramuscular administration Methods 0.000 description 7
- 230000000881 depressing effect Effects 0.000 description 6
- 229920002457 flexible plastic Polymers 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 239000000017 hydrogel Substances 0.000 description 6
- 230000003204 osmotic effect Effects 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000000717 retained effect Effects 0.000 description 6
- 238000010254 subcutaneous injection Methods 0.000 description 6
- 239000007929 subcutaneous injection Substances 0.000 description 6
- 108010081589 Becaplermin Proteins 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 230000003068 static effect Effects 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 238000007920 subcutaneous administration Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 206010006784 Burning sensation Diseases 0.000 description 4
- 108010008165 Etanercept Proteins 0.000 description 4
- 108010050904 Interferons Proteins 0.000 description 4
- 102000014150 Interferons Human genes 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 102100040247 Tumor necrosis factor Human genes 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 238000005336 cracking Methods 0.000 description 4
- 108010067396 dornase alfa Proteins 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000004146 energy storage Methods 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229960001743 golimumab Drugs 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 229940079322 interferon Drugs 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 3
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 102100040990 Platelet-derived growth factor subunit B Human genes 0.000 description 3
- HYNPZTKLUNHGPM-KKERQHFVSA-N becaplermin Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCCN5C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]6CCCN6C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]7CCCN7C(=O)[C@H](Cc8c[nH]c9c8cccc9)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)N HYNPZTKLUNHGPM-KKERQHFVSA-N 0.000 description 3
- 229960004787 becaplermin Drugs 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229960000403 etanercept Drugs 0.000 description 3
- 210000004602 germ cell Anatomy 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 230000000069 prophylactic effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229960005267 tositumomab Drugs 0.000 description 3
- RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 description 2
- MJZJYWCQPMNPRM-UHFFFAOYSA-N 6,6-dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,6-dihydro-1,3,5-triazine-2,4-diamine Chemical compound CC1(C)N=C(N)N=C(N)N1OCCCOC1=CC(Cl)=C(Cl)C=C1Cl MJZJYWCQPMNPRM-UHFFFAOYSA-N 0.000 description 2
- 102000015790 Asparaginase Human genes 0.000 description 2
- 108010024976 Asparaginase Proteins 0.000 description 2
- 108010019673 Darbepoetin alfa Proteins 0.000 description 2
- 108010074604 Epoetin Alfa Proteins 0.000 description 2
- 108010029961 Filgrastim Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101001018026 Homo sapiens Lysosomal alpha-glucosidase Proteins 0.000 description 2
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 2
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 108010078049 Interferon alpha-2 Proteins 0.000 description 2
- 102000051628 Interleukin-1 receptor antagonist Human genes 0.000 description 2
- 108700021006 Interleukin-1 receptor antagonist Proteins 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 108010039185 Tenecteplase Proteins 0.000 description 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 108010056760 agalsidase beta Proteins 0.000 description 2
- 108700025316 aldesleukin Proteins 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 229960003115 certolizumab pegol Drugs 0.000 description 2
- 108010084052 continuous erythropoietin receptor activator Proteins 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 229960000533 dornase alfa Drugs 0.000 description 2
- 229940073621 enbrel Drugs 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 108010089296 galsulfase Proteins 0.000 description 2
- 229960003297 gemtuzumab ozogamicin Drugs 0.000 description 2
- 102000045921 human GAA Human genes 0.000 description 2
- 229940048921 humira Drugs 0.000 description 2
- 229960001001 ibritumomab tiuxetan Drugs 0.000 description 2
- 108010072166 idursulfase Proteins 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 108010010648 interferon alfacon-1 Proteins 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 108010046821 oprelvekin Proteins 0.000 description 2
- 229960001972 panitumumab Drugs 0.000 description 2
- 108010044644 pegfilgrastim Proteins 0.000 description 2
- 108010092853 peginterferon alfa-2a Proteins 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 229940107568 pulmozyme Drugs 0.000 description 2
- 108010084837 rasburicase Proteins 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 229940116157 regranex Drugs 0.000 description 2
- 229940116176 remicade Drugs 0.000 description 2
- 108010051412 reteplase Proteins 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 108010074523 rimabotulinumtoxinB Proteins 0.000 description 2
- 229960004641 rituximab Drugs 0.000 description 2
- 108010017584 romiplostim Proteins 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 229960003824 ustekinumab Drugs 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- HMLGSIZOMSVISS-ONJSNURVSA-N (7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@@H]1C(N2C(=C(C=C)CSC21)C(O)=O)=O)C(=O)\C(=N/OCOC(=O)C(C)(C)C)C1=CSC(N)=N1 HMLGSIZOMSVISS-ONJSNURVSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101710117542 Botulinum neurotoxin type A Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229940122601 Esterase inhibitor Drugs 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 1
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101001081555 Homo sapiens Plasma protease C1 inhibitor Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102100029199 Iduronate 2-sulfatase Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 206010069803 Injury associated with device Diseases 0.000 description 1
- 108010005716 Interferon beta-1a Proteins 0.000 description 1
- 108010005714 Interferon beta-1b Proteins 0.000 description 1
- 102100030694 Interleukin-11 Human genes 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- 208000012266 Needlestick injury Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- 108010057266 Type A Botulinum Toxins Proteins 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- XYVNHPYNSPGYLI-UUOKFMHZSA-N [(2r,3s,4r,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O XYVNHPYNSPGYLI-UUOKFMHZSA-N 0.000 description 1
- 229960003697 abatacept Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940099550 actimmune Drugs 0.000 description 1
- 229940099983 activase Drugs 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960003227 afelimomab Drugs 0.000 description 1
- 229960004470 agalsidase beta Drugs 0.000 description 1
- 229960005310 aldesleukin Drugs 0.000 description 1
- 229940022705 aldurazyme Drugs 0.000 description 1
- 229960002459 alefacept Drugs 0.000 description 1
- 229960000548 alemtuzumab Drugs 0.000 description 1
- 229960004593 alglucosidase alfa Drugs 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 229960003318 alteplase Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 229960004238 anakinra Drugs 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 229940115115 aranesp Drugs 0.000 description 1
- 229940094361 arcalyst Drugs 0.000 description 1
- 229950005725 arcitumomab Drugs 0.000 description 1
- 229960003272 asparaginase Drugs 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 1
- 229940090047 auto-injector Drugs 0.000 description 1
- 229940120638 avastin Drugs 0.000 description 1
- 229960004669 basiliximab Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940021459 betaseron Drugs 0.000 description 1
- 229960000397 bevacizumab Drugs 0.000 description 1
- 229940125385 biologic drug Drugs 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 229940089093 botox Drugs 0.000 description 1
- 229940094657 botulinum toxin type a Drugs 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229940112129 campath Drugs 0.000 description 1
- 229940034605 capromab pendetide Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229960005395 cetuximab Drugs 0.000 description 1
- 229940090100 cimzia Drugs 0.000 description 1
- 229940088949 cinryze Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229960002806 daclizumab Drugs 0.000 description 1
- 229960005029 darbepoetin alfa Drugs 0.000 description 1
- 108010017271 denileukin diftitox Proteins 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940056176 drotrecogin alfa Drugs 0.000 description 1
- 108010008250 drotrecogin alfa activated Proteins 0.000 description 1
- 229960002224 eculizumab Drugs 0.000 description 1
- 229960001776 edrecolomab Drugs 0.000 description 1
- 229940012882 elaprase Drugs 0.000 description 1
- KUBARPMUNHKBIQ-VTHUDJRQSA-N eliglustat tartrate Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.C([C@@H](NC(=O)CCCCCCC)[C@H](O)C=1C=C2OCCOC2=CC=1)N1CCCC1.C([C@@H](NC(=O)CCCCCCC)[C@H](O)C=1C=C2OCCOC2=CC=1)N1CCCC1 KUBARPMUNHKBIQ-VTHUDJRQSA-N 0.000 description 1
- 229940053603 elitek Drugs 0.000 description 1
- 229940073038 elspar Drugs 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229960003388 epoetin alfa Drugs 0.000 description 1
- 229940089118 epogen Drugs 0.000 description 1
- 229940082789 erbitux Drugs 0.000 description 1
- 239000002329 esterase inhibitor Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 229940014516 fabrazyme Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 229960004177 filgrastim Drugs 0.000 description 1
- 229960005390 galsulfase Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940022353 herceptin Drugs 0.000 description 1
- 239000011796 hollow space material Substances 0.000 description 1
- 102000044507 human SERPING1 Human genes 0.000 description 1
- 229960002396 idursulfase Drugs 0.000 description 1
- 229950007354 imciromab Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229940090438 infergen Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960003521 interferon alfa-2a Drugs 0.000 description 1
- 229960003358 interferon alfacon-1 Drugs 0.000 description 1
- 108010042414 interferon gamma-1b Proteins 0.000 description 1
- 229940065638 intron a Drugs 0.000 description 1
- 229940065223 kepivance Drugs 0.000 description 1
- 229940054136 kineret Drugs 0.000 description 1
- 229960002486 laronidase Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 229960001046 methoxy polyethylene glycol-epoetin beta Drugs 0.000 description 1
- 229940029238 mircera Drugs 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229960003816 muromonab-cd3 Drugs 0.000 description 1
- 229940112646 myobloc Drugs 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229940103023 myozyme Drugs 0.000 description 1
- 229940068704 naglazyme Drugs 0.000 description 1
- 229940071846 neulasta Drugs 0.000 description 1
- 229940082926 neumega Drugs 0.000 description 1
- 229940029345 neupogen Drugs 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229960000470 omalizumab Drugs 0.000 description 1
- 229940100027 ontak Drugs 0.000 description 1
- 229960001840 oprelvekin Drugs 0.000 description 1
- 229940035567 orencia Drugs 0.000 description 1
- 229960002404 palifermin Drugs 0.000 description 1
- 229960000402 palivizumab Drugs 0.000 description 1
- HQQSBEDKMRHYME-UHFFFAOYSA-N pefloxacin mesylate Chemical compound [H+].CS([O-])(=O)=O.C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCN(C)CC1 HQQSBEDKMRHYME-UHFFFAOYSA-N 0.000 description 1
- 229940002988 pegasys Drugs 0.000 description 1
- 229960001373 pegfilgrastim Drugs 0.000 description 1
- 229960003930 peginterferon alfa-2a Drugs 0.000 description 1
- 229940067082 pentetate Drugs 0.000 description 1
- 229940071643 prefilled syringe Drugs 0.000 description 1
- 229940087463 proleukin Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229960000424 rasburicase Drugs 0.000 description 1
- 229940038850 rebif Drugs 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940107685 reopro Drugs 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940116243 retavase Drugs 0.000 description 1
- 229960002917 reteplase Drugs 0.000 description 1
- 108010046141 rilonacept Proteins 0.000 description 1
- 229960001886 rilonacept Drugs 0.000 description 1
- 229960004262 romiplostim Drugs 0.000 description 1
- WUWDLXZGHZSWQZ-WQLSENKSSA-N semaxanib Chemical compound N1C(C)=CC(C)=C1\C=C/1C2=CC=CC=C2NC\1=O WUWDLXZGHZSWQZ-WQLSENKSSA-N 0.000 description 1
- 229940115586 simulect Drugs 0.000 description 1
- 229940055944 soliris Drugs 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940036185 synagis Drugs 0.000 description 1
- 229960000216 tenecteplase Drugs 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 229940113038 tnkase Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940099073 xolair Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
- A61M5/2455—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic with sealing means to be broken or opened
- A61M5/2466—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic with sealing means to be broken or opened by piercing without internal pressure increase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3202—Devices for protection of the needle before use, e.g. caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/322—Retractable needles, i.e. disconnected from and withdrawn into the syringe barrel by the piston
- A61M5/3232—Semi-automatic needle retraction, i.e. in which triggering of the needle retraction requires a deliberate action by the user, e.g. manual release of spring-biased retraction means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/322—Retractable needles, i.e. disconnected from and withdrawn into the syringe barrel by the piston
- A61M5/3234—Fully automatic needle retraction, i.e. in which triggering of the needle does not require a deliberate action by the user
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
- A61M2005/14252—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
- A61M5/2455—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic with sealing means to be broken or opened
- A61M5/2466—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic with sealing means to be broken or opened by piercing without internal pressure increase
- A61M2005/247—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic with sealing means to be broken or opened by piercing without internal pressure increase with fixed or steady piercing means, e.g. piercing under movement of ampoule
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Environmental & Geological Engineering (AREA)
- Diabetes (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016203871A AU2016203871B2 (en) | 2011-04-21 | 2016-06-09 | Wearable automatic injection device |
| AU2018201981A AU2018201981C1 (en) | 2011-04-21 | 2018-03-20 | Wearable automatic injection device |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161478039P | 2011-04-21 | 2011-04-21 | |
| US61/478,039 | 2011-04-21 | ||
| PCT/US2012/034683 WO2012145752A2 (en) | 2011-04-21 | 2012-04-23 | Wearable automatic injection device for controlled administration of therapeutic agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016203871A Division AU2016203871B2 (en) | 2011-04-21 | 2016-06-09 | Wearable automatic injection device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2012245211A1 AU2012245211A1 (en) | 2013-05-02 |
| AU2012245211B2 true AU2012245211B2 (en) | 2016-03-10 |
Family
ID=46046324
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012245211A Ceased AU2012245211B2 (en) | 2011-04-21 | 2012-04-23 | Wearable automatic injection device |
| AU2016203871A Ceased AU2016203871B2 (en) | 2011-04-21 | 2016-06-09 | Wearable automatic injection device |
| AU2018201981A Active AU2018201981C1 (en) | 2011-04-21 | 2018-03-20 | Wearable automatic injection device |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016203871A Ceased AU2016203871B2 (en) | 2011-04-21 | 2016-06-09 | Wearable automatic injection device |
| AU2018201981A Active AU2018201981C1 (en) | 2011-04-21 | 2018-03-20 | Wearable automatic injection device |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US9956345B2 (enExample) |
| EP (3) | EP4299093A3 (enExample) |
| JP (2) | JP6066995B2 (enExample) |
| CN (2) | CN103619378B (enExample) |
| AU (3) | AU2012245211B2 (enExample) |
| CA (1) | CA2832729A1 (enExample) |
| ES (1) | ES2605817T3 (enExample) |
| MX (1) | MX345747B (enExample) |
| WO (1) | WO2012145752A2 (enExample) |
Families Citing this family (132)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101440795B1 (ko) | 2006-06-30 | 2014-09-22 | 애브비 바이오테크놀로지 리미티드 | 자동 주사 장치 |
| US7967795B1 (en) | 2010-01-19 | 2011-06-28 | Lamodel Ltd. | Cartridge interface assembly with driving plunger |
| US10420880B2 (en) | 2007-10-02 | 2019-09-24 | West Pharma. Services IL, Ltd. | Key for securing components of a drug delivery system during assembly and/or transport and methods of using same |
| US9656019B2 (en) | 2007-10-02 | 2017-05-23 | Medimop Medical Projects Ltd. | Apparatuses for securing components of a drug delivery system during transport and methods of using same |
| US9345836B2 (en) | 2007-10-02 | 2016-05-24 | Medimop Medical Projects Ltd. | Disengagement resistant telescoping assembly and unidirectional method of assembly for such |
| BRPI0817907B8 (pt) | 2007-10-02 | 2021-06-22 | Lamodel Ltd | aparelho para administrar uma substância a um indivíduo |
| US8052645B2 (en) | 2008-07-23 | 2011-11-08 | Avant Medical Corp. | System and method for an injection using a syringe needle |
| MX2010012691A (es) | 2008-05-20 | 2011-03-30 | Avant Medical Corp Star | Sistema auto-inyector. |
| US9393369B2 (en) | 2008-09-15 | 2016-07-19 | Medimop Medical Projects Ltd. | Stabilized pen injector |
| US12097357B2 (en) | 2008-09-15 | 2024-09-24 | West Pharma. Services IL, Ltd. | Stabilized pen injector |
| US10071196B2 (en) | 2012-05-15 | 2018-09-11 | West Pharma. Services IL, Ltd. | Method for selectively powering a battery-operated drug-delivery device and device therefor |
| US10071198B2 (en) | 2012-11-02 | 2018-09-11 | West Pharma. Servicees IL, Ltd. | Adhesive structure for medical device |
| US8157769B2 (en) | 2009-09-15 | 2012-04-17 | Medimop Medical Projects Ltd. | Cartridge insertion assembly for drug delivery system |
| US8348898B2 (en) | 2010-01-19 | 2013-01-08 | Medimop Medical Projects Ltd. | Automatic needle for drug pump |
| CN104906656B (zh) | 2010-04-21 | 2020-01-10 | 艾伯维生物技术有限公司 | 用于治疗药剂的受控输送的可佩戴自动注射装置 |
| WO2011141907A1 (en) | 2010-05-10 | 2011-11-17 | Medimop Medical Projects Ltd. | Low volume accurate injector |
| WO2012123274A1 (en) | 2011-03-14 | 2012-09-20 | Unomedical A/S | Inserter system with transport protection |
| USD702834S1 (en) | 2011-03-22 | 2014-04-15 | Medimop Medical Projects Ltd. | Cartridge for use in injection device |
| CA2833748C (en) | 2011-04-20 | 2019-07-16 | Amgen Inc. | Autoinjector apparatus |
| EP3335747B1 (en) | 2011-10-14 | 2021-04-07 | Amgen Inc. | Injector and method of assembly |
| CN104245014B (zh) | 2012-01-31 | 2017-05-24 | 麦迪麦珀医疗项目有限公司 | 时间依赖性的药物输送装置 |
| CA2866843C (en) * | 2012-03-12 | 2020-04-21 | Unitract Syringe Pty Ltd | Fill-finish cartridges for sterile fluid pathway assemblies and drug delivery devices incorporating fill-finish cartridges |
| US10668213B2 (en) | 2012-03-26 | 2020-06-02 | West Pharma. Services IL, Ltd. | Motion activated mechanisms for a drug delivery device |
| US9072827B2 (en) | 2012-03-26 | 2015-07-07 | Medimop Medical Projects Ltd. | Fail safe point protector for needle safety flap |
| US9463280B2 (en) * | 2012-03-26 | 2016-10-11 | Medimop Medical Projects Ltd. | Motion activated septum puncturing drug delivery device |
| PL4201327T3 (pl) | 2012-03-30 | 2024-11-04 | Insulet Corporation | Urządzenie do dostarczania płynu z narzędziem dostępu przezskórnego, mechanizmem wprowadzającym i monitorowaniem poziomu glukozy we krwi do stosowania z nim |
| USD898908S1 (en) | 2012-04-20 | 2020-10-13 | Amgen Inc. | Pharmaceutical product cassette for an injection device |
| US9421323B2 (en) | 2013-01-03 | 2016-08-23 | Medimop Medical Projects Ltd. | Door and doorstop for portable one use drug delivery apparatus |
| CN111617347B (zh) * | 2013-03-15 | 2023-09-29 | 安进公司 | 身体轮廓可调适的自动注射器装置 |
| US10492990B2 (en) | 2013-03-15 | 2019-12-03 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
| EP2976117B1 (en) | 2013-03-22 | 2020-12-30 | Amgen Inc. | Injector and method of assembly |
| US9011164B2 (en) | 2013-04-30 | 2015-04-21 | Medimop Medical Projects Ltd. | Clip contact for easy installation of printed circuit board PCB |
| JP6491195B2 (ja) | 2013-05-03 | 2019-03-27 | ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ | 流体経路サブアセンブリ |
| US9889256B2 (en) | 2013-05-03 | 2018-02-13 | Medimop Medical Projects Ltd. | Sensing a status of an infuser based on sensing motor control and power input |
| WO2014204894A2 (en) | 2013-06-18 | 2014-12-24 | Enable Injections, Llc | Vial transfer and injection apparatus and method |
| GB201313888D0 (en) | 2013-08-02 | 2013-09-18 | Consort Medical Plc | Assembly for an autoinjector device |
| EP3052166B1 (en) * | 2013-09-30 | 2019-04-17 | Medimop Medical Projects Ltd. | Adhesive cover peeler and needle cover remover for autoinjector |
| SG11201602876WA (en) | 2013-10-24 | 2016-05-30 | Amgen Inc | Injector and method of assembly |
| CN110141719B (zh) * | 2013-12-19 | 2022-05-27 | 美敦力迷你迈德公司 | 贴身注射器及其使用方法 |
| GB201402261D0 (en) | 2014-02-10 | 2014-03-26 | Owen Mumford Ltd | Injector apparatus |
| SG10201811702TA (en) | 2014-05-07 | 2019-01-30 | Amgen Inc | Autoinjector with shock reducing elements |
| CN106659845A (zh) | 2014-05-20 | 2017-05-10 | 瑟丘尔股份有限公司 | 具有操作受限的填充端口的药物输送装置 |
| MX387194B (es) | 2014-06-03 | 2025-03-18 | Amgen Inc | Sistemas y metodos para procesar de manera remota datos recolectados por un dispositivo de suministro de farmaco. |
| KR102192419B1 (ko) * | 2014-09-11 | 2020-12-17 | 삼성전자주식회사 | 웨어러블 장치를 사용하여 전자 장치를 제어하는 방법 및 전자 장치의 동작 방법 |
| GB201416985D0 (en) * | 2014-09-26 | 2014-11-12 | Ucb Biopharma Sprl And Bespak Europ Ltd | Housing part for an auto-injector |
| CN113332524B (zh) * | 2014-10-18 | 2023-11-10 | 艾伯维公司 | 可穿戴自动注射系统和设备 |
| US10799630B2 (en) * | 2014-12-19 | 2020-10-13 | Amgen Inc. | Drug delivery device with proximity sensor |
| EP3689394A1 (en) | 2014-12-19 | 2020-08-05 | Amgen Inc. | Drug delivery device with live button or user interface field |
| CN107530502B (zh) | 2015-02-20 | 2021-01-15 | 里珍纳龙药品有限公司 | 注射器系统、活塞密封系统、塞子系统 |
| US9795534B2 (en) | 2015-03-04 | 2017-10-24 | Medimop Medical Projects Ltd. | Compliant coupling assembly for cartridge coupling of a drug delivery device |
| US10251813B2 (en) | 2015-03-04 | 2019-04-09 | West Pharma. Services IL, Ltd. | Flexibly mounted cartridge alignment collar for drug delivery device |
| KR102634489B1 (ko) * | 2015-03-10 | 2024-02-07 | 리제너론 파아마슈티컬스, 인크. | 무균 관통 시스템 및 방법 |
| US10293120B2 (en) | 2015-04-10 | 2019-05-21 | West Pharma. Services IL, Ltd. | Redundant injection device status indication |
| US9744297B2 (en) | 2015-04-10 | 2017-08-29 | Medimop Medical Projects Ltd. | Needle cannula position as an input to operational control of an injection device |
| JP7073107B2 (ja) | 2015-05-01 | 2022-05-23 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・リーランド・スタンフォード・ジュニア・ユニバーシティ | 臍帯断端を保護するためのシステム及び方法 |
| US10149943B2 (en) | 2015-05-29 | 2018-12-11 | West Pharma. Services IL, Ltd. | Linear rotation stabilizer for a telescoping syringe stopper driverdriving assembly |
| EP4252798A3 (en) | 2015-06-04 | 2023-10-25 | Medimop Medical Projects Ltd. | Cartridge insertion for drug delivery device |
| US10086145B2 (en) | 2015-09-22 | 2018-10-02 | West Pharma Services Il, Ltd. | Rotation resistant friction adapter for plunger driver of drug delivery device |
| US9987432B2 (en) | 2015-09-22 | 2018-06-05 | West Pharma. Services IL, Ltd. | Rotation resistant friction adapter for plunger driver of drug delivery device |
| US10576207B2 (en) * | 2015-10-09 | 2020-03-03 | West Pharma. Services IL, Ltd. | Angled syringe patch injector |
| US11065381B2 (en) | 2015-10-05 | 2021-07-20 | E3D A.C.A.L. | Infusion pump device and method for use thereof |
| CN112972833B (zh) | 2015-10-09 | 2024-01-09 | 西医药服务以色列分公司 | 注射器针帽脱离器 |
| CN108348292B (zh) * | 2015-10-27 | 2021-04-27 | 纳诺帕斯技术有限公司 | 具有机械性导引的微针装置 |
| EP3162395A1 (en) | 2015-10-28 | 2017-05-03 | NNE Pharmaplan A/S | Single-use auto-injector |
| WO2017087888A1 (en) | 2015-11-18 | 2017-05-26 | President And Fellows Of Harvard College | Systems and methods for monitoring, managing, and treating asthma and anaphylaxis |
| EP3383454B1 (en) | 2015-11-30 | 2020-02-12 | Sanofi-Aventis Deutschland GmbH | Packaging assembly |
| GB2545266B (en) | 2015-12-11 | 2018-08-08 | Oval Medical Tech Limited | Autoinjector with retracting needle |
| JP6542481B2 (ja) | 2016-01-21 | 2019-07-10 | ウェスト ファーマ サービシーズ イスラエル リミテッド | システム |
| JP6885960B2 (ja) | 2016-01-21 | 2021-06-16 | ウェスト ファーマ サービシーズ イスラエル リミテッド | 視覚的インジケータを有する薬剤デリバリデバイス |
| CN109219456B (zh) | 2016-01-21 | 2020-05-15 | 西医药服务以色列有限公司 | 自动注射器中的力牵制 |
| JP6914947B2 (ja) * | 2016-01-28 | 2021-08-04 | サブクジェクト・エピエス | 着用可能な注入デバイス |
| US11389597B2 (en) | 2016-03-16 | 2022-07-19 | West Pharma. Services IL, Ltd. | Staged telescopic screw assembly having different visual indicators |
| US10376647B2 (en) | 2016-03-18 | 2019-08-13 | West Pharma. Services IL, Ltd. | Anti-rotation mechanism for telescopic screw assembly |
| WO2017205816A1 (en) | 2016-05-26 | 2017-11-30 | Insulet Corporation | Single dose drug delivery device |
| CN109310831B (zh) | 2016-06-02 | 2021-11-23 | 西医药服务以色列有限公司 | 三位置针缩回 |
| US20170348479A1 (en) | 2016-06-03 | 2017-12-07 | Bryan Choate | Adhesive system for drug delivery device |
| US10751476B2 (en) * | 2016-06-09 | 2020-08-25 | Becton, Dickinson And Company | Actuator assembly for drug delivery system |
| US10603445B2 (en) | 2016-06-09 | 2020-03-31 | Becton, Dickinson And Company | Needle actuator assembly for drug delivery system |
| US10792432B2 (en) | 2016-06-09 | 2020-10-06 | Becton, Dickinson And Company | Drive assembly and spacer for drug delivery system |
| US10549044B2 (en) | 2016-06-09 | 2020-02-04 | Becton, Dickinson And Company | Spacer assembly for drug delivery system |
| EP3490635B1 (en) | 2016-08-01 | 2021-11-17 | West Pharma. Services Il, Ltd. | Partial door closure prevention spring |
| CN109562229B (zh) | 2016-08-01 | 2021-07-13 | 西医药服务以色列有限公司 | 抗旋转药筒销 |
| EP3496789A1 (en) | 2016-08-14 | 2019-06-19 | Insulet Corporation | Automatic drug delivery device with trigger mechanism |
| JP2019528951A (ja) * | 2016-09-27 | 2019-10-17 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 薬剤送達デバイス |
| EP3522951A1 (en) * | 2016-10-07 | 2019-08-14 | Insulet Corporation | Multi-stage delivery system |
| US10780217B2 (en) | 2016-11-10 | 2020-09-22 | Insulet Corporation | Ratchet drive for on body delivery system |
| EP3544658B1 (en) | 2016-11-22 | 2024-07-03 | LTS Device Technologies Ltd | Apparatus for delivering a therapeutic substance |
| WO2018136699A1 (en) | 2017-01-19 | 2018-07-26 | Insulet Corporation | Cartridge hold-up volume reduction |
| TW201829004A (zh) | 2017-01-31 | 2018-08-16 | 澳洲商優尼揣克注射器有限公司 | 藥物遞送裝置之無菌連接件 |
| DK3884973T3 (da) | 2017-02-24 | 2023-02-27 | Sanofi Sa | Emballageenhed til injektionsenheder |
| EP3585457B1 (en) | 2017-02-24 | 2023-11-01 | Sanofi | Packaging assembly |
| US10695485B2 (en) | 2017-03-07 | 2020-06-30 | Insulet Corporation | Very high volume user filled drug delivery device |
| EP3398630A1 (en) * | 2017-05-03 | 2018-11-07 | Sanofi-Aventis Deutschland GmbH | Auto-injector storage device |
| ES2919934T3 (es) | 2017-05-05 | 2022-07-29 | Regeneron Pharma | Autoinyector y procedimientos de uso relacionados |
| EP3624846B1 (en) | 2017-05-16 | 2024-08-07 | Bhami's Research Laboratory, Pvt. Ltd. | High concentration protein formulations with reduced viscosity including a combination of nicotinic acid and tryoptophan |
| JP6921997B2 (ja) | 2017-05-30 | 2021-08-18 | ウェスト ファーマ サービシーズ イスラエル リミテッド | ウェアラブル注射器のモジュラ駆動トレイン |
| EP3634546A1 (en) | 2017-06-08 | 2020-04-15 | Amgen Inc. | Torque driven drug delivery device |
| BR122020018051B1 (pt) | 2017-07-07 | 2022-10-04 | Neuroderm Ltd | Dispositivo para aplicação subcutânea de medicamento fluido |
| US20230123806A1 (en) | 2017-07-07 | 2023-04-20 | Neuroderm, Ltd. | Device for subcutaneous delivery of fluid medicament |
| EP4375504A3 (en) | 2017-08-03 | 2024-06-26 | Insulet Corporation | Micro piston pump |
| US10973978B2 (en) | 2017-08-03 | 2021-04-13 | Insulet Corporation | Fluid flow regulation arrangements for drug delivery devices |
| US11786668B2 (en) | 2017-09-25 | 2023-10-17 | Insulet Corporation | Drug delivery devices, systems, and methods with force transfer elements |
| US11357918B2 (en) | 2017-10-16 | 2022-06-14 | Becton, Dickinson And Company | Spacer assembly for drug delivery device |
| WO2019126421A1 (en) | 2017-12-22 | 2019-06-27 | West Pharma. Services Il., Ltd. | Injector usable with different dimension cartridges |
| TWI699494B (zh) * | 2018-01-24 | 2020-07-21 | 美商伊路米納有限公司 | 流體緩衝 |
| WO2019150145A1 (en) * | 2018-01-31 | 2019-08-08 | Unitract Syringe Pty Ltd | Aseptic connections for drug delivery devices |
| EP3539591A1 (en) * | 2018-03-15 | 2019-09-18 | Tecpharma Licensing AG | An injection or infusion device comprising an improved release liner |
| US20210196892A1 (en) * | 2018-04-11 | 2021-07-01 | Sanofi | Drug Delivery Device |
| WO2019197360A1 (en) * | 2018-04-11 | 2019-10-17 | Sanofi | Drug delivery device |
| US10874803B2 (en) | 2018-05-31 | 2020-12-29 | Insulet Corporation | Drug cartridge with drive system |
| WO2019236818A1 (en) | 2018-06-06 | 2019-12-12 | Insulet Corporation | Linear shuttle pump for drug delivery |
| EP3810248A4 (en) | 2018-06-25 | 2022-04-27 | Novonate, Inc. | SYSTEMS AND METHODS OF ATTACHING CATHETER |
| US20210213203A1 (en) * | 2018-07-06 | 2021-07-15 | Irenix Medical, Inc. | Active Agent Delivery Devices and Methods for Using the Same |
| JP7307147B2 (ja) | 2018-07-17 | 2023-07-11 | インスレット コーポレイション | 薬剤送出ポンプ用の低い起動力を有するバルブ |
| EP3632487B1 (en) | 2018-10-05 | 2024-06-12 | LTS Device Technologies Ltd | Triggering sequence |
| JP7161618B2 (ja) | 2018-11-28 | 2022-10-26 | インスレット コーポレイション | 薬物送達シャトルポンプシステムと弁アセンブリ |
| BR112021015064A2 (pt) * | 2019-02-12 | 2021-09-28 | Becton, Dickinson And Company | Tampa para desinfecção de um dispositivo médico |
| US12263256B2 (en) | 2019-02-12 | 2025-04-01 | Becton, Dickinson And Company | Medical device to disinfect a skin surface |
| USD907768S1 (en) | 2019-06-21 | 2021-01-12 | Novonate, Inc. | Catheter securing device |
| CN110279913B (zh) * | 2019-07-24 | 2024-04-09 | 李嘉翔 | 一种扣压式胰岛素注射器 |
| WO2021127270A1 (en) * | 2019-12-19 | 2021-06-24 | Novonate, Inc. | Catheter interface protection device manipulation tools |
| EP4192549A4 (en) * | 2020-08-07 | 2024-08-14 | Becton, Dickinson and Company | MEDICAL DEVICE FOR DISINFECTING A SKIN SURFACE |
| US12097352B2 (en) | 2020-08-27 | 2024-09-24 | Insulet Corporation | Wearable micro-dosing drug delivery device |
| KR20230128023A (ko) | 2020-12-31 | 2023-09-01 | 리제너론 파아마슈티컬스, 인크. | 자동 주사기 및 관련 사용 방법 |
| CN116782966A (zh) | 2021-01-08 | 2023-09-19 | 英赛罗公司 | 单致动精确剂量中间泵送室 |
| US12440617B2 (en) | 2021-01-11 | 2025-10-14 | Insulet Corporation | Linear activated drug dosing pump system |
| US12491310B2 (en) * | 2021-01-12 | 2025-12-09 | Insulet Corporation | Wearable drug delivery device with removal element |
| US11738140B2 (en) * | 2021-01-15 | 2023-08-29 | Medtronic Minimed, Inc. | Insertion device with linkage assembly |
| EP4346945A1 (en) | 2021-05-28 | 2024-04-10 | Insulet Corporation | Spring-based status sensors |
| US12406760B2 (en) | 2021-06-07 | 2025-09-02 | Insulet Corporation | Exercise safety prediction based on physiological conditions |
| USD1007676S1 (en) | 2021-11-16 | 2023-12-12 | Regeneron Pharmaceuticals, Inc. | Wearable autoinjector |
| CN114129827B (zh) * | 2021-11-30 | 2024-01-19 | 苏州和林微纳科技股份有限公司 | 一种无针注射器的垂直注射机构 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5860957A (en) * | 1997-02-07 | 1999-01-19 | Sarcos, Inc. | Multipathway electronically-controlled drug delivery system |
| US20010025168A1 (en) * | 1997-06-16 | 2001-09-27 | Elan Corporation Plc | Pre-filled drug-delivery device and method of manufacture and assembly of same |
| WO2004024211A2 (en) * | 2002-09-12 | 2004-03-25 | Children's Hospital Medical Center | Method and device for painless injection of medication |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3824859A (en) * | 1972-02-04 | 1974-07-23 | R Harris | Automatic fluid injector |
| US3910260A (en) | 1972-03-01 | 1975-10-07 | Survival Technology | Method and apparatus of treating heart attack patients prior to the establishment of qualified direct contact personal care |
| US4004577A (en) | 1972-12-04 | 1977-01-25 | Survival Technology, Inc. | Method of treating heart attack patients prior to the establishment of qualified direct contact personal care |
| US3941130A (en) | 1975-03-18 | 1976-03-02 | Tibbs Robert C | Sequential trigger release for injection device |
| US4261358A (en) | 1979-10-01 | 1981-04-14 | Walter Vargas | Automatic syringe plunger |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4795433A (en) | 1985-05-20 | 1989-01-03 | Survival Technology, Inc. | Automatic injector for emergency treatment |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| US4689042A (en) | 1985-05-20 | 1987-08-25 | Survival Technology, Inc. | Automatic medicament ingredient mixing and injecting apparatus |
| WO1987002671A1 (en) | 1985-11-01 | 1987-05-07 | International Genetic Engineering, Inc. | Modular assembly of antibody genes, antibodies prepared thereby and use |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| SE466604B (sv) | 1988-10-26 | 1992-03-09 | Arne Lundin | Anordning foer provtagning och transport av vaetskeformiga media |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5085642A (en) | 1989-07-17 | 1992-02-04 | Survival Technology, Inc. | Conveniently carried frequent use autoinjector |
| US5102393A (en) | 1989-07-17 | 1992-04-07 | Survival Technology, Inc. | Autoinjector converted from intramuscular to subcutaneous mode of injection |
| US5959087A (en) | 1989-08-07 | 1999-09-28 | Peptide Technology, Ltd. | Tumour necrosis factor binding ligands |
| US6448380B2 (en) | 1989-08-07 | 2002-09-10 | Peptech Limited | Tumor necrosis factor antibodies |
| AU630497B2 (en) | 1989-09-05 | 1992-10-29 | Immunex Corporation | Tumor necrosis factor-alpha and -beta receptors |
| US5092843A (en) | 1990-04-12 | 1992-03-03 | Survival Technology, Inc. | Dispersion multichamber auto-injector |
| US5656272A (en) | 1991-03-18 | 1997-08-12 | New York University Medical Center | Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies |
| US5267963A (en) | 1992-08-21 | 1993-12-07 | Nicholas Bachynsky | Medication injection device |
| JPH07504203A (ja) | 1992-09-15 | 1995-05-11 | イミュネックス・コーポレーション | 腫瘍壊死因子アンタゴニストを用いるｔｎｆ−依存性炎症の治療方法 |
| IE77523B1 (en) | 1995-09-11 | 1997-12-17 | Elan Med Tech | Medicament delivery device |
| US6090382A (en) | 1996-02-09 | 2000-07-18 | Basf Aktiengesellschaft | Human antibodies that bind human TNFα |
| US5858001A (en) * | 1995-12-11 | 1999-01-12 | Elan Medical Technologies Limited | Cartridge-based drug delivery device |
| DE69721548T2 (de) | 1996-02-09 | 2004-04-01 | Abbott Laboratories(Bermuda)Ltd. | HUMANE ANTIKÖRPER WELCHE AN HUMANEN TNFalpha BINDEN |
| DE69826003D1 (de) * | 1997-06-16 | 2004-10-07 | Elan Corp Plc | Vorgefüllte medikamentenabgabevorrichtung |
| US6149626A (en) | 1997-10-03 | 2000-11-21 | Bachynsky; Nicholas | Automatic injecting syringe apparatus |
| AU3050499A (en) * | 1998-03-23 | 1999-10-18 | Elan Corporation, Plc | Drug delivery device |
| SE9803662D0 (sv) | 1998-10-26 | 1998-10-26 | Pharmacia & Upjohn Ab | Autoinjector |
| UA81743C2 (uk) | 2000-08-07 | 2008-02-11 | Центокор, Инк. | МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ |
| AUPR867901A0 (en) * | 2001-11-05 | 2001-11-29 | University of Newcastel Research Associates Limited, The | 'Liquid dispenser' |
| CN1726059A (zh) * | 2002-11-05 | 2006-01-25 | M2医药有限公司 | 一种一次性可穿戴的胰岛素分配装置,这种装置和一个程序控制器的组合以及控制这种装置工作的方法 |
| BRPI0413538B8 (pt) * | 2003-08-12 | 2021-06-22 | Becton Dickison And Company | dispositivo para fornecer um medicamento para o corpo de um paciente por injeção |
| KR101440795B1 (ko) | 2006-06-30 | 2014-09-22 | 애브비 바이오테크놀로지 리미티드 | 자동 주사 장치 |
| BRPI0817907B8 (pt) * | 2007-10-02 | 2021-06-22 | Lamodel Ltd | aparelho para administrar uma substância a um indivíduo |
| BRPI0918297A2 (pt) * | 2008-09-10 | 2016-05-03 | Hoffmann La Roche | "dispositivo de distribuição de droga para bombear a medicação para dentro do corpo de um usuário" |
| US8152779B2 (en) * | 2008-12-30 | 2012-04-10 | Medimop Medical Projects Ltd. | Needle assembly for drug pump |
| CA2921304C (en) | 2009-07-30 | 2018-06-05 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
| US10010706B2 (en) * | 2009-07-31 | 2018-07-03 | 3M Innovative Properties Company | Hollow microneedle arrays |
| IT1395574B1 (it) | 2009-09-14 | 2012-10-16 | Guala Dispensing Spa | Dispositivo di erogazione |
| CN104906656B (zh) * | 2010-04-21 | 2020-01-10 | 艾伯维生物技术有限公司 | 用于治疗药剂的受控输送的可佩戴自动注射装置 |
-
2012
- 2012-04-23 CA CA2832729A patent/CA2832729A1/en active Pending
- 2012-04-23 EP EP23209369.0A patent/EP4299093A3/en active Pending
- 2012-04-23 AU AU2012245211A patent/AU2012245211B2/en not_active Ceased
- 2012-04-23 US US14/111,933 patent/US9956345B2/en active Active
- 2012-04-23 CN CN201280030740.9A patent/CN103619378B/zh not_active Expired - Fee Related
- 2012-04-23 MX MX2013012318A patent/MX345747B/es active IP Right Grant
- 2012-04-23 WO PCT/US2012/034683 patent/WO2012145752A2/en not_active Ceased
- 2012-04-23 JP JP2014506619A patent/JP6066995B2/ja not_active Expired - Fee Related
- 2012-04-23 ES ES12719852.1T patent/ES2605817T3/es active Active
- 2012-04-23 CN CN201710050009.7A patent/CN107096098A/zh active Pending
- 2012-04-23 EP EP15185881.8A patent/EP3020428A1/en not_active Withdrawn
- 2012-04-23 EP EP12719852.1A patent/EP2699286B1/en active Active
-
2016
- 2016-06-08 JP JP2016114216A patent/JP2016185339A/ja not_active Ceased
- 2016-06-09 AU AU2016203871A patent/AU2016203871B2/en not_active Ceased
-
2018
- 2018-03-20 AU AU2018201981A patent/AU2018201981C1/en active Active
- 2018-04-30 US US15/966,809 patent/US20180250472A1/en not_active Abandoned
-
2021
- 2021-03-01 US US17/189,162 patent/US20220023544A1/en not_active Abandoned
-
2024
- 2024-01-22 US US18/419,519 patent/US20250018121A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5860957A (en) * | 1997-02-07 | 1999-01-19 | Sarcos, Inc. | Multipathway electronically-controlled drug delivery system |
| US20010025168A1 (en) * | 1997-06-16 | 2001-09-27 | Elan Corporation Plc | Pre-filled drug-delivery device and method of manufacture and assembly of same |
| WO2004024211A2 (en) * | 2002-09-12 | 2004-03-25 | Children's Hospital Medical Center | Method and device for painless injection of medication |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018201981A1 (en) | 2018-04-12 |
| US9956345B2 (en) | 2018-05-01 |
| EP2699286A2 (en) | 2014-02-26 |
| US20180250472A1 (en) | 2018-09-06 |
| EP4299093A2 (en) | 2024-01-03 |
| CN103619378A (zh) | 2014-03-05 |
| AU2012245211A1 (en) | 2013-05-02 |
| US20140148784A1 (en) | 2014-05-29 |
| CN103619378B (zh) | 2017-03-01 |
| AU2016203871A1 (en) | 2016-06-30 |
| JP2014515669A (ja) | 2014-07-03 |
| CA2832729A1 (en) | 2012-10-26 |
| EP4299093A3 (en) | 2024-03-13 |
| WO2012145752A3 (en) | 2013-04-18 |
| MX345747B (es) | 2017-02-14 |
| JP2016185339A (ja) | 2016-10-27 |
| ES2605817T3 (es) | 2017-03-16 |
| JP6066995B2 (ja) | 2017-01-25 |
| CN107096098A (zh) | 2017-08-29 |
| US20250018121A1 (en) | 2025-01-16 |
| US20220023544A1 (en) | 2022-01-27 |
| MX2013012318A (es) | 2014-01-31 |
| EP3020428A1 (en) | 2016-05-18 |
| AU2018201981C1 (en) | 2020-04-16 |
| WO2012145752A2 (en) | 2012-10-26 |
| AU2018201981B2 (en) | 2019-11-21 |
| WO2012145752A8 (en) | 2013-02-07 |
| EP2699286B1 (en) | 2016-08-31 |
| AU2016203871B2 (en) | 2017-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250018121A1 (en) | Wearable automatic injection device for controlled administration of therapeutic agents | |
| US20210178074A1 (en) | Wearable automatic injection device for controlled delivery of therapeutic agents | |
| HK1195020B (en) | Wearable automatic injection device | |
| AU2018202116B2 (en) | Wearable automatic injection device for controlled delivery of therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: ABBVIE INC. Free format text: FORMER APPLICANT(S): ABBOTT LABORATORIES |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ ANDERSON, PHILIP D.; JULIAN, JOSEPH F.; LAURUSONIS, LINAS P.; CORRIGAN, SEAN; STRAHM, CHRIS; MATUSAITIS, TOMAS AND FIENUP, WILLIAM . |
|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ ANDERSON, PHILIP D.; JULIAN, JOSEPH F.; LAURUSONIS, LINAS P.; CORRIGAN, SEAN; STRAHM, CHRIS; MATUSAITIS, TOMAS AND FIENUP, WILLIAM |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |